25, 2025 – The FDA has approved a new treatment plan for a long-acting injection, making it easier for people with moderate to severe opioid use ... Once injected, it forms a gel under the ...

Opioid prescription is common practice following extreme pain resulting ... According to Brown, to fully understand the opioid epidemic, it is important to understand that illicit forms of opiates, ...

Academic cites challenges of addiction after Monash University finds many injured workers receiving 'high-risk' prescriptions ...

RICHMOND, Va. (WRIC) — The U.S. Food and Drug Administration (FDA) has approved Journavx, the first opioid-free prescription drug for moderate to severe acute pain in more than 20 years.

The analysis of health insurance claims data from almost 3 million U.S. patients investigated prescribed stimulants' impact on prescription opioid use over 10 years, looking for origins of the so ...